Management of Toxicities of BTK Inhibitors in B-Cell Malignancies |
0.75 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Waldenström Macroglobulinemia |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Managing Multiple Medications – Polypharmacy |
0.50 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
Managing Pain in Cancer Survivors |
0.25 |
08/04/2022 - 12:00am to 08/04/2024 - 12:00am |
May 2023 BCOP Test - Changing Treatment Paradigms in Chronic Lymphocytic Leukemia |
|
02/28/2023 - 12:00am to 05/24/2024 - 11:59pm |
May 2023 BCOP Test - The Role of PD-L1 Therapy in the Early Treatment of Triple Negative Breast Cancer |
|
02/28/2023 - 12:00am to 05/31/2024 - 11:59pm |
Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas |
1.00 |
03/19/2024 - 12:00am to 08/04/2024 - 12:00am |
Monthly Oncology Tumor Boards: Management of Early-Stage Non-Small Cell Lung Cancer |
1.00 |
01/09/2024 - 12:00am to 04/30/2024 - 12:00am |
Monthly Oncology Tumor Boards: Management of Pheochromocytoma and Paraganglioma |
1.00 |
06/29/2023 - 12:00am to 07/21/2024 - 12:00am |
Monthly Oncology Tumor Boards: Sequencing Therapies for Patients with Metastatic HER2-Negative Breast Cancer |
1.00 |
01/09/2024 - 12:00am to 05/05/2024 - 12:00am |
Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer |
1.00 |
02/13/2024 - 12:00am to 07/07/2024 - 12:00am |
Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia |
1.00 |
03/19/2024 - 12:00am to 08/04/2024 - 12:00am |
Multigene and Biomarker Testing in Breast Cancer |
1.00 |
03/15/2024 - 12:00am to 03/15/2025 - 12:00am |
Navigating Change: Best Practices for Integrating WHO/ICC Classification Systems in the Management of Hematologic Malignancies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Navigating the Challenges: Effective Management of Toxicities in CAR T-Cell Therapies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |